Table 1 Characteristics of articles in the meta-analysis on chemotherapy and luminal A breast cancer
Author, year | Country, follow-up (median) | Study design | Sample size | Chemotherapy regimen | Outcome indicators |
|---|---|---|---|---|---|
Uchida et al.2013 [10] | Japan, 3–113 (40) months | Retrospective study | 140 | FEC × 4/FEC × 4-docetaxel × 4 or paclitaxel × 4 | RFS, OS |
Kwak et al. 2015 [16] | South Korea, 28–116 (61) months | Retrospective study | 879 | No detail description | DFS, OS |
Han et al. 2015 [17] | China, 60–89 (67) months | Retrospective cohort study | 1580 | AC × 4/AC × 6 | DFS, OS |
Nielsen et al. 2016 [18] | UK, 10 years (median) | Clinical trial | 1072 (luminal A n = 165) | C × 12/CMF × 12 | DFS, OS (not provided) |
Alramadhan et al. 2016 [19] | South Korea, 51.3 ± 18.9(median) | Retrospective study | 406 | AC × 4/FAC × 4 | DFS, OS (not provided) |
Herr et al. 2019 [20] | Multicenter, - | Retrospective multicenter Study | 1376 | A/AT | RFS, OS |